Price
chg
chg neg
quotes and stock data may be delayed 15 minutes
My Notes
Only BPIQ Pro members can create company notes. Learn more here.
52 wk low
low api
52 wk hi
high api
Cash
$67.2 M
Burn Rate (Qtr)
N/A
Mkt Cap
mkt cap api
Avg Volume
volume api
*cash/burn updated:
Q4 '21
Drug Pipeline
Click the button to see the updated pipeline
No drug found
We don't have any drug data for this company yet
Drug | Disease (links)
Stage (next event)
Catalyst Date
Loading Catalysts...
search in progress
Pipeline powered by
ATRS
Company Profile
ATRS was acquired by HALO on 5/24/2022
Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. With a goal of improving dosing, reducing side effects, and improving patient compliance and outcomes, our pursuit of innovative therapies strives to positively affect patients’ lives.
Recent Posts
See what the community is saying - click to see full post.